Correction: Evaluation of bloodstream infections, Clostridium difficile infections, and gut microbiota in pediatric oncology patients.

[This corrects the article DOI: 10.1371/journal.pone.0191232.].

There is an error in Table 1. Please see the correct Table 1 here.

Table 1

Clinical characteristics of pediatric oncology patients.

		All	Clostridium difficile Colonization1		All Bacteremia2
					Positive	Negative	Positive	Negative
Subjects		42	21% (9)	79% (33)	21% (9)	79% (33)
Sex (F)		60% (25)	89% (8)	52% (17)	56% (5)	61% (20)
Previous Cancer Diagnosis (Y)		81% (34)	100% (9)	76% (25)	89% (8)	79% (26)
Admission Type
New Diagnosis		19% (8)	0% (0)	24% (8)	11% (1)	21% (7)
Chemotherapy		26% (11)	33% (3)	24% (8)	44% (4)	21% (7)
Fever/Neutropenia		21% (9)	33% (3)	18% (6)	11% (1)	24% (8)
	Other	33% (14)	33% (3)	33% (11)	33% (3)	33% (11)
Patient Type
ALL		36% (15)	11% (1)	42% (14)	22% (2)	39% (13)
AML		10% (4)	11% (1)	9% (3)	33% (3)	3% (1)
BMT		12% (5)	22% (2)	9% (3)	22% (2)	9% (3)
Solid		33% (14)	44% (4)	30% (10)	11% (1)	39% (13)
Heme		10% (4)	11% (1)	9% (3)	11% (1)	9% (3)
Median 16S Reads		84,108	109,661	80,424	84,841	83,375
Age (years)	Median (Range)	7.41 (0.31–22.2)	6.57 (0.57–20.0)	7.68 (0.31–22.2)	9.87 (2.17–22.2)	7.13 (0.31–20.3)
BMI (kg/m2)3	Median (Range)	17.1 (12.9–28.9)	18.3 (13.7–23.1)	17.0 (12.9–28.9)	17.23 (15.3–22.8)	17.05 (12.9–28.9)

1 Assessed by toxin-specific PCR of stool specimens.

2 Assessed by clinical blood culture

3 Body Mass Index (BMI)